El-Heneidy, A. et al. 2026. Nirsevimab provides age-specific protection against RSV hospitalisation in the first year of life: a population-level study in Queensland, Australia. Communicable Diseases Intelligence. 50, (Oct. 2026). DOI:https://doi.org/10.33321/cdi.2026.50.066.